Sales rise 441.29% to Rs 32.64 crore
Net loss of Genpharmasec reported to Rs 1.18 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales rose 441.29% to Rs 32.64 crore in the quarter ended September 2025 as against Rs 6.03 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales32.646.03 441 OPM %-1.441.99 -PBDT-0.230.81 PL PBT-0.800.50 PL NP-1.180.70 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
